The Japan Prostate Cancer Imaging Market is valued at USD 345.5 million in 2023 and is expected to reach USD 438.0 million by 2030, with a CAGR of 3.4% from 2024 to 2030.   This growth is fueled by the rising cases of prostate cancer among Japan's aging male population and the increased awareness of early detection through improved imaging solutions like MRI, PET-CT, and ultrasound fusion...